TACC3 and cancer: The molecular alterations observed upon TACC3 knockout in CA tumors in vivo were also recapitulated upon short-term induction of shRNA-mediated TACC3 knockdown or inhibition with BO-264 in JIMT-1 xenografts (Supplementary Fig. S9A, B).